Tuning P450 Enzymes as Oxidation Catalysts

The development of catalytic systems for the controlled oxidation of C–H bonds remains a highly sought-after goal in chemistry owing to the great utility of such transformation toward expediting the synthesis and functionalization of organic molecules. Cytochrome P450 monooxygenases are the catalysts of choice in the biological world for mediating the oxidation of sp3 and sp2 C–H bonds with a high degree of chemo-, regio-, and stereoselectivity and in a wide array of compounds of varying complexity. The efficiency of these enzymes, compared with chemical methods, to catalyze the insertion of oxygen into unactivated C–H bonds under mild reaction conditions has sparked interest among researchers toward investigating and exploiting P450s for a variety of synthetic applications. Realizing the synthetic potential of these enzymes, however, depends upon the availability of effective strategies to tune the reactivity of natural P450s to obtain viable oxidation catalysts for the desired transformation. This revie...

[1]  L. Wong,et al.  The catalytic activity of cytochrome P450cam towards styrene oxidation is increased by site‐specific mutagenesis , 1997, FEBS letters.

[2]  Frances H Arnold,et al.  Directed enzyme evolution: climbing fitness peaks one amino acid at a time. , 2009, Current opinion in chemical biology.

[3]  P. Grootenhuis,et al.  Efficient Screening of Cytochrome P450 BM3 Mutants for Their Metabolic Activity and Diversity toward a Wide Set of Drug-Like Molecules in Chemical Space , 2011, Drug Metabolism and Disposition.

[4]  O. Shoji,et al.  Aromatic C–H bond hydroxylation by P450 peroxygenases: a facile colorimetric assay for monooxygenation activities of enzymes based on Russig’s blue formation , 2010, JBIC Journal of Biological Inorganic Chemistry.

[5]  J. Falck,et al.  An Active Site Substitution, F87V, Converts Cytochrome P450 BM-3 into a Regio- and Stereoselective (14S,15R)-Arachidonic Acid Epoxygenase* , 1997, The Journal of Biological Chemistry.

[6]  V. Urlacher,et al.  Altering the Regioselectivity of Cytochrome P450 CYP102A3 of Bacillus subtilis by Using a New Versatile Assay System , 2006, Chembiochem : a European journal of chemical biology.

[7]  K. Auclair,et al.  Predictable stereoselective and chemoselective hydroxylations and epoxidations with P450 3A4. , 2011, Journal of the American Chemical Society.

[8]  C. W. Fisher,et al.  Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Chiung-Kuang J. Chen,et al.  Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene ω-hydroxylase CYP4C7 , 2010, JBIC Journal of Biological Inorganic Chemistry.

[10]  T. Shimada,et al.  Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification. , 1996, Archives of biochemistry and biophysics.

[11]  O. Shoji,et al.  Understanding substrate misrecognition of hydrogen peroxide dependent cytochrome P450 from Bacillus subtilis , 2010, JBIC Journal of Biological Inorganic Chemistry.

[12]  Tristan R. Brown,et al.  Engineered Bacterial Mimics of Human Drug Metabolizing Enzyme CYP2C9 , 2011 .

[13]  H. Murakami,et al.  Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase in Saccharomyces cerevisiae. , 1990, DNA and cell biology.

[14]  B. Gabriele,et al.  Catalytic oxidations of steroid substrates by artificial cytochrome p-450 enzymes. , 2002, The Journal of organic chemistry.

[15]  Frances H Arnold,et al.  Evolutionary history of a specialized p450 propane monooxygenase. , 2008, Journal of molecular biology.

[16]  Heung-Chae Jung,et al.  ENGINEERING BACTERIAL CYTOCHROME P450 BM3 INTO A PROTOTYPE WITH HUMAN P450 ENZYME ACTIVITY USING INDIGO FORMATION , 2010 .

[17]  Nicholas J Turner,et al.  Engineering and improvement of the efficiency of a chimeric [P450cam-RhFRed reductase domain] enzyme. , 2009, Chemical communications.

[18]  C. Wolf,et al.  Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison. , 1999, Drug metabolism reviews.

[19]  G. Brudvig,et al.  High turnover remote catalytic oxygenation of alkyl groups: how steric exclusion of unbound substrate contributes to high molecular recognition selectivity. , 2008, Journal of the American Chemical Society.

[20]  W U Primrose,et al.  A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. , 1997, Biochemistry.

[21]  Martin Stahl,et al.  Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.

[22]  Rudi Fasan,et al.  P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity. , 2011, Journal of the American Chemical Society.

[23]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[24]  M. Budde,et al.  Selective Hydroxylation of Highly Branched Fatty Acids and their Derivatives by CYP102A1 from Bacillus megaterium , 2006, Chembiochem : a European journal of chemical biology.

[25]  H. Griengl,et al.  The use of substrate engineering in biohydroxylation. , 2002, Current opinion in biotechnology.

[26]  Jullien Drone,et al.  A regioselective biocatalyst for alkane activation under mild conditions. , 2011, Angewandte Chemie.

[27]  D. Sherman,et al.  Engineering and analysis of a self-sufficient biosynthetic cytochrome P450 PikC fused to the RhFRED reductase domain. , 2007, Journal of the American Chemical Society.

[28]  I. Schlichting,et al.  Structural aspects of ligand binding to and electron transfer in bacterial and fungal P450s. , 2004, Annual review of biochemistry.

[29]  O. Gotoh,et al.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.

[30]  Vlada B Urlacher,et al.  Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. , 2011, Chemical communications.

[31]  C. W. Fisher,et al.  The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase. , 1996, Archives of biochemistry and biophysics.

[32]  M. Koffas,et al.  Engineering Central Metabolic Pathways for High-Level Flavonoid Production in Escherichia coli , 2007, Applied and Environmental Microbiology.

[33]  T. Poulos,et al.  High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.

[34]  J. Capdevila,et al.  Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains. , 2000, Biochemistry.

[35]  H. Sugimoto,et al.  Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. , 2011, The Journal of biological chemistry.

[36]  L. Sayavedra-Soto,et al.  Molecular analysis of the soluble butane monooxygenase from 'Pseudomonas butanovora'. , 2002, Microbiology.

[37]  Frances H. Arnold,et al.  Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase , 2002, Nature Biotechnology.

[38]  M. Sanford,et al.  Palladium-catalyzed oxygenation of unactivated sp3 C-H bonds. , 2004, Journal of the American Chemical Society.

[39]  Denis Pompon,et al.  Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast , 1998, Nature Biotechnology.

[40]  F. Diederich,et al.  Fluorine in Pharmaceuticals: Looking Beyond Intuition , 2007, Science.

[41]  Kersten S. Rabe,et al.  Engineering and assaying of cytochrome P450 biocatalysts , 2008, Analytical and bioanalytical chemistry.

[42]  E. Gillam,et al.  A shuffled CYP2C library with a high degree of structural integrity and functional versatility. , 2007, Archives of biochemistry and biophysics.

[43]  Michael T. Green,et al.  Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics , 2010, Science.

[44]  A. Burlingame,et al.  Cytochrome P450cin (CYP176A), Isolation, Expression, and Characterization* , 2002, The Journal of Biological Chemistry.

[45]  J. Groves The bioinorganic chemistry of iron in oxygenases and supramolecular assemblies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Godula,et al.  C-H Bond Functionalization in Complex Organic Synthesis , 2006, Science.

[47]  J Deisenhofer,et al.  Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.

[48]  U. Mueller,et al.  Structural fine-tuning of a multifunctional cytochrome P450 monooxygenase. , 2011, Journal of the American Chemical Society.

[49]  Huimin Zhao,et al.  Combinatorial Design of a Highly Efficient Xylose-Utilizing Pathway in Saccharomyces cerevisiae for the Production of Cellulosic Biofuels , 2012, Applied and Environmental Microbiology.

[50]  O. Sibbesen,et al.  Putidaredoxin Reductase-Putidaredoxin-Cytochrome P450cam Triple Fusion Protein , 1996, The Journal of Biological Chemistry.

[51]  F. Arnold,et al.  Catalysts on Demand: Selective Oxidations by Laboratory-Evolved Cytochrome P450 BM3 , 2009 .

[52]  E. G. Funhoff,et al.  CYP153A6, a Soluble P450 Oxygenase Catalyzing Terminal-Alkane Hydroxylation , 2006, Journal of bacteriology.

[53]  F. Arnold,et al.  Enzymatic functionalization of carbon-hydrogen bonds. , 2011, Chemical Society reviews.

[54]  F. Arnold,et al.  Engineering Cytochrome P450 BM3 for Terminal Alkane Hydroxylation , 2006 .

[55]  T. Sakaki,et al.  Molecular Engineering Study on Electron Transfer from NADPH-P450 Reductase to Rat Mitochondrial P450c27 in Yeast Microsomes* , 1996, The Journal of Biological Chemistry.

[56]  Stephen G. Sligar,et al.  Kinetic Characterization of Compound I Formation in the Thermostable Cytochrome P450 CYP119* , 2002, The Journal of Biological Chemistry.

[57]  F. Arnold,et al.  Diversification of catalytic function in a synthetic family of chimeric cytochrome p450s. , 2007, Chemistry & biology.

[58]  N. Vermeulen,et al.  Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. , 2007, Journal of medicinal chemistry.

[59]  Matthias Dietrich,et al.  Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions. , 2009, Journal of biotechnology.

[60]  Paul N. Devine,et al.  Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture , 2010, Science.

[61]  T. Maier,et al.  Molecular characterization of the 56-kDa CYP153 from Acinetobacter sp. EB104. , 2001, Biochemical and biophysical research communications.

[62]  Chiung-Kuang J. Chen,et al.  The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity , 2008, JBIC Journal of Biological Inorganic Chemistry.

[63]  F. Arnold,et al.  Protein stability promotes evolvability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[64]  W. Atkins,et al.  Interactions of cytochrome P450s with their ligands. , 2011, Archives of biochemistry and biophysics.

[65]  Qing-Shan Li,et al.  Hydroxylation activity of P450 BM-3 mutant F87V towards aromatic compounds and its application to the synthesis of hydroquinone derivatives from phenolic compounds , 2005, Applied Microbiology and Biotechnology.

[66]  Manfred T Reetz,et al.  Tuning a p450 enzyme for methane oxidation. , 2011, Angewandte Chemie.

[67]  F. Guengerich,et al.  A tricistronic human adrenodoxin reductase-adrenodoxin-cytochrome P450 27A1 vector system for substrate hydroxylation in Escherichia coli. , 2011, Protein expression and purification.

[68]  Micheal C. Wilson,et al.  Shared biosynthesis of the saliniketals and rifamycins in Salinispora arenicola is controlled by the sare1259-encoded cytochrome P450. , 2010, Journal of the American Chemical Society.

[69]  K. Inouye,et al.  Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. , 2000, Archives of biochemistry and biophysics.

[70]  D. Sherman,et al.  Selective oxidation of carbolide C–H bonds by an engineered macrolide P450 mono-oxygenase , 2009, Proceedings of the National Academy of Sciences.

[71]  Sabine Laschat,et al.  Rational Design of a Minimal and Highly Enriched CYP102A1 Mutant Library with Improved Regio‐, Stereo‐ and Chemoselectivity , 2009, Chembiochem : a European journal of chemical biology.

[72]  G. Brudvig,et al.  Molecular Recognition in the Selective Oxygenation of Saturated C-H Bonds by a Dimanganese Catalyst , 2006, Science.

[73]  R. Bernhardt,et al.  Cytochrome P450 systems--biological variations of electron transport chains. , 2007, Biochimica et biophysica acta.

[74]  U. Schwaneberg,et al.  A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes. , 2001, Journal of biotechnology.

[75]  H. Inui,et al.  Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5. , 2007, Biochemistry.

[76]  P. Fuchs,et al.  Chemospecific chromium[VI] catalyzed oxidation of C-H bonds at -40 °C , 2002 .

[77]  G. Gaskell Science policy and society: the British debate over GM agriculture. , 2004, Current opinion in biotechnology.

[78]  R. Schmid,et al.  Engineering Cytochrome P450 BM-3 for Oxidation of Polycyclic Aromatic Hydrocarbons , 2001, Applied and Environmental Microbiology.

[79]  F. Guengerich,et al.  Drug metabolism by Escherichia coli expressing human cytochromes P450 , 1997, Nature Biotechnology.

[80]  T. Poulos,et al.  The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.

[81]  M. Honing,et al.  Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11 , 2011, JBIC Journal of Biological Inorganic Chemistry.

[82]  G. Gilardi,et al.  Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego , 2005, JBIC Journal of Biological Inorganic Chemistry.

[83]  O. Shoji,et al.  Hydrogen peroxide dependent monooxygenations by tricking the substrate recognition of cytochrome P450BSbeta. , 2007, Angewandte Chemie.

[84]  Rapid identification of cytochrome P450cam variants by in vivo screening of active site libraries , 2004 .

[85]  L. Narhi,et al.  Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. , 1987, The Journal of biological chemistry.

[86]  P. Hedden,et al.  The P450–1 gene of Gibberella fujikuroi encodes a multifunctional enzyme in gibberellin biosynthesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[87]  D. Sames,et al.  Selective functionalization of amino acids in water: a synthetic method via catalytic C-H bond activation. , 2001, Journal of the American Chemical Society.

[88]  S. Sligar,et al.  Nucleotide sequence of the Pseudomonas putida cytochrome P-450cam gene and its expression in Escherichia coli. , 1986, The Journal of biological chemistry.

[89]  P. Baran,et al.  If C-H bonds could talk: selective C-H bond oxidation. , 2011, Angewandte Chemie.

[90]  B. Witholt,et al.  Preparation of (R)- and (S)-N-protected 3-hydroxypyrrolidines by hydroxylation with Sphingomonas sp. HXN-200, a highly active, regio- and stereoselective, and easy to handle biocatalyst. , 2001, The Journal of organic chemistry.

[91]  S. Bell,et al.  Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3. , 2005, Organic & biomolecular chemistry.

[92]  Surendra S. Negi,et al.  Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains , 2006, Journal of Biological Chemistry.

[93]  M. White,et al.  Combined Effects on Selectivity in Fe-Catalyzed Methylene Oxidation , 2010, Science.

[94]  H. Shoun,et al.  Cytochrome P450foxy, a catalytically self-sufficient fatty acid hydroxylase of the fungus Fusarium oxysporum. , 1996, Journal of biochemistry.

[95]  J. Dawson,et al.  Reaction of Ferric Cytochrome P450cam with Peracids , 2005, Journal of Biological Chemistry.

[96]  F Peter Guengerich,et al.  Complex reactions catalyzed by cytochrome P450 enzymes. , 2007, Biochimica et biophysica acta.

[97]  Ramesh N. Patel Biocatalysis: Synthesis of Key Intermediates for Development of Pharmaceuticals , 2011 .

[98]  Elizabeth M J Gillam,et al.  Extending the diversity of cytochrome P450 enzymes by DNA family shuffling. , 2007, Gene.

[99]  F. Arnold,et al.  Improved product‐per‐glucose yields in P450‐dependent propane biotransformations using engineered Escherichia coli , 2011, Biotechnology and bioengineering.

[100]  Frances H Arnold,et al.  Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. , 2003, Journal of the American Chemical Society.

[101]  C. Chiang,et al.  Structures of Prostacyclin Synthase and Its Complexes with Substrate Analog and Inhibitor Reveal a Ligand-specific Heme Conformation Change* , 2008, Journal of Biological Chemistry.

[102]  C. W. Fisher,et al.  Comparison of the 17α-Hydroxylase/C17,20-Lyase Activities of Porcine, Guinea Pig and Bovine P450c17 Using Purified Recombinant Fusion Proteins Containing P450c17 Linked to NADPH-P450 Reductase , 2007, Drug metabolism reviews.

[103]  G. Brudvig,et al.  Molecular recognition in homogeneous transition metal catalysis: a biomimetic strategy for high selectivity. , 2008, Chemical communications.

[104]  N. Kitteringham,et al.  Metabolism of fluorine-containing drugs. , 2001, Annual review of pharmacology and toxicology.

[105]  D. Sherman,et al.  Hydroxylation of macrolactones YC-17 and narbomycin is mediated by the pikC-encoded cytochrome P450 in Streptomyces venezuelae. , 1998, Chemistry & biology.

[106]  Imad Hanna,et al.  Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli , 2005, Journal of Industrial Microbiology and Biotechnology.

[107]  M. Waterman,et al.  Studies of distant members of the P450 superfamily (P450scc and P450c27) by random chimeragenesis. , 1996, Archives of biochemistry and biophysics.

[108]  J. Dawson,et al.  Heme-Containing Oxygenases. , 1996, Chemical reviews.

[109]  A. Alian,et al.  Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450(cam) by an L244A mutation. , 2006, Protein engineering, design & selection : PEDS.

[110]  A. Munro,et al.  Roles of key active-site residues in flavocytochrome P450 BM3. , 1999, The Biochemical journal.

[111]  P. Covello,et al.  Artemisia annua L. (Asteraceae) trichome‐specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin , 2006, FEBS letters.

[112]  F. Arnold,et al.  Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.

[113]  S. Bell,et al.  Butane and propane oxidation by engineered cytochrome P450cam. , 2002, Chemical communications.

[114]  N. Vermeulen,et al.  Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. , 2006, Biochemical and biophysical research communications.

[115]  F. Guengerich Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[116]  C. Wolf,et al.  Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein. , 2001, Archives of biochemistry and biophysics.

[117]  F. Arnold,et al.  Combinatorial Alanine Substitution Enables Rapid Optimization of Cytochrome P450BM3 for Selective Hydroxylation of Large Substrates , 2010, Chembiochem : a European journal of chemical biology.

[118]  M. Schittmayer,et al.  A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabolite Synthesis , 2009 .

[119]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[120]  D. Haines,et al.  Cloning, expression and characterization of a fast self-sufficient P450: CYP102A5 from Bacillus cereus. , 2007, Archives of biochemistry and biophysics.

[121]  R. Bernhardt,et al.  Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.

[122]  D. Ro,et al.  Loblolly pine abietadienol/abietadienal oxidase PtAO (CYP720B1) is a multifunctional, multisubstrate cytochrome P450 monooxygenase , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[123]  J. Slattery,et al.  CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes. , 1998, Journal of pharmaceutical sciences.

[124]  M. Cryle,et al.  Carbon-carbon bond cleavage by cytochrome p450(BioI)(CYP107H1). , 2004, Chemical communications.

[125]  E. G. Funhoff,et al.  Hydroxylation and epoxidation reactions catalyzed by CYP153 enzymes , 2007 .

[126]  J. Falck,et al.  The Highly Stereoselective Oxidation of Polyunsaturated Fatty Acids by Cytochrome P450BM-3* , 1996, The Journal of Biological Chemistry.

[127]  U. Schwaneberg,et al.  Directed evolution of oxygenases: screening systems, success stories and challenges. , 2007, Combinatorial chemistry & high throughput screening.

[128]  Milton R. Smith,et al.  C-H activation/borylation/oxidation: a one-pot unified route to meta-substituted phenols bearing ortho-/para-directing groups. , 2003, Journal of the American Chemical Society.

[129]  R. Schmid,et al.  Residue size at position 87 of cytochrome P450 BM‐3 determines its stereoselectivity in propylbenzene and 3‐chlorostyrene oxidation , 2001, FEBS letters.

[130]  M. Sanford,et al.  A highly selective catalytic method for the oxidative functionalization of C-H bonds. , 2004, Journal of the American Chemical Society.

[131]  Andreas Schmid,et al.  Practical issues in the application of oxygenases. , 2003, Trends in biotechnology.

[132]  S. Takatsuto,et al.  Arabidopsis CYP85A2, a Cytochrome P450, Mediates the Baeyer-Villiger Oxidation of Castasterone to Brassinolide in Brassinosteroid Biosynthesis , 2005, The Plant Cell Online.

[133]  R D Schmid,et al.  Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst. , 2000, Chemistry.

[134]  Bernhard Hauer,et al.  An Efficient Route to Selective Bio‐oxidation Catalysts: an Iterative Approach Comprising Modeling, Diversification, and Screening, Based on CYP102A1 , 2011, Chembiochem : a European journal of chemical biology.

[135]  Youngchang Kim,et al.  The Structural Basis for Substrate Anchoring, Active Site Selectivity, and Product Formation by P450 PikC from Streptomyces venezuelae* , 2006, Journal of Biological Chemistry.

[136]  J. Halpert,et al.  A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5* , 2003, The Journal of Biological Chemistry.

[137]  L. Wong,et al.  Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. , 2001, European journal of biochemistry.

[138]  F. Arnold,et al.  Thermostabilization of a Cytochrome P450 Peroxygenase , 2003, Chembiochem : a European journal of chemical biology.

[139]  O. Shoji,et al.  Use of perfluorocarboxylic acids to trick cytochrome P450BM3 into initiating the hydroxylation of gaseous alkanes. , 2011, Angewandte Chemie.

[140]  Paul A Wender,et al.  Late-stage intermolecular CH activation for lead diversification: a highly chemoselective oxyfunctionalization of the C-9 position of potent bryostatin analogues. , 2005, Organic letters.

[141]  Frances H Arnold,et al.  Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450 BM-3. , 2006, Chemistry.

[142]  Frances H Arnold,et al.  Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450BM3 demethylases , 2009, Proceedings of the National Academy of Sciences.

[143]  Raquel L Lieberman,et al.  Biological Methane Oxidation: Regulation, Biochemistry, and Active Site Structure of Particulate Methane Monooxygenase , 2004, Critical reviews in biochemistry and molecular biology.

[144]  F. Arnold,et al.  Direct Conversion of Ethane to Ethanol by Engineered Cytochrome P450 BM3 , 2005, Chembiochem : a European journal of chemical biology.

[145]  Jeffrey B. Endelman,et al.  Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450 , 2006, PLoS biology.

[146]  I. Pikuleva CHOLESTEROL-METABOLIZING CYTOCHROMES P450 , 2006, Drug Metabolism and Disposition.

[147]  John H. White,et al.  Probing the substrate specificity of the catalytically self-sufficient cytochrome P450 RhF from a Rhodococcus sp. , 2006, Chemical communications.

[148]  M. White,et al.  A Predictably Selective Aliphatic C–H Oxidation Reaction for Complex Molecule Synthesis , 2007, Science.

[149]  V. Urlacher,et al.  Biotransformation of β-ionone by engineered cytochrome P450 BM-3 , 2006, Applied Microbiology and Biotechnology.

[150]  Jay D Keasling,et al.  Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. , 2007, Nature chemical biology.

[151]  G. Gilardi,et al.  Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes , 2007, JBIC Journal of Biological Inorganic Chemistry.

[152]  F. Arnold,et al.  Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3. , 2005, Chemical communications.

[153]  L. Wong,et al.  Protein engineering of cytochrome p450(cam) (CYP101) for the oxidation of polycyclic aromatic hydrocarbons. , 2000, Protein engineering.

[154]  J. D. Bois,et al.  Oxaziridine-Mediated Catalytic Hydroxylation of Unactivated 3° C−H Bonds Using Hydrogen Peroxide , 2005 .

[155]  S. Bell,et al.  Engineering the CYP101 system for in vivo oxidation of unnatural substrates. , 2001, Protein engineering.

[156]  S. Bell,et al.  The heme monooxygenase cytochrome P450cam can be engineered to oxidize ethane to ethanol. , 2005, Angewandte Chemie.

[157]  L. Wong,et al.  Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450(cam)). , 2001, European journal of biochemistry.

[158]  Heung-Chae Jung,et al.  Generation of the Human Metabolite Piceatannol from the Anticancer-Preventive Agent Resveratrol by Bacterial Cytochrome P450 BM3 , 2009, Drug Metabolism and Disposition.

[159]  Frances H Arnold,et al.  Chemo-enzymatic fluorination of unactivated organic compounds. , 2009, Nature chemical biology.

[160]  Dong-Sun Lee,et al.  Substrate Recognition and Molecular Mechanism of Fatty Acid Hydroxylation by Cytochrome P450 from Bacillus subtilis , 2003, The Journal of Biological Chemistry.

[161]  R. J. Kenny,et al.  Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. , 2008, Chemical communications.

[162]  K. Suslick,et al.  Shape selective alkane hydroxylation by metalloporphyrin catalysts , 1987 .

[163]  G. B. Shul’pin,et al.  ACTIVATION OF C-H BONDS BY METAL COMPLEXES , 1997 .

[164]  M. Cryle,et al.  Are branched chain fatty acids the natural substrates for P450(BM3)? , 2006, Chemical communications.

[165]  F. Walker,et al.  Chimeragenesis of the fatty acid binding site of cytochrome P450BM3. Replacement of residues 73-84 with the homologous residues from the insect cytochrome P450 CYP4C7. , 2004, Biochemistry.

[166]  S. Bell,et al.  Engineering the haem monooxygenase cytochrome P450cam for monoterpene oxidation , 2001 .

[167]  Thomas C Pochapsky,et al.  Conformational plasticity and structure/function relationships in cytochromes P450. , 2010, Antioxidants & redox signaling.

[168]  M. Gelb,et al.  Stereochemistry and deuterium isotope effects in camphor hydroxylation by the cytochrome P450cam monoxygenase system. , 1982, Biochemistry.

[169]  N. Bruce,et al.  LICRED: A Versatile Drop‐In Vector for Rapid Generation of Redox‐Self‐Sufficient Cytochrome P450s , 2010, Chembiochem : a European journal of chemical biology.

[170]  J. Coggins,et al.  Probing electron transfer in flavocytochrome P-450 BM3 and its component domains. , 1996, European journal of biochemistry.

[171]  Teruyuki Nagamune,et al.  Intramolecular electron transfer in a cytochrome P450cam system with a site-specific branched structure. , 2006, Protein engineering, design & selection : PEDS.

[172]  Ilme Schlichting,et al.  Structure and chemistry of cytochrome P450. , 2005, Chemical reviews.

[173]  Heung-Chae Jung,et al.  Generation of Human Chiral Metabolites of Simvastatin and Lovastatin by Bacterial CYP102A1 Mutants , 2011, Drug Metabolism and Disposition.

[174]  Frances H Arnold,et al.  Cytochrome P450: taming a wild type enzyme. , 2011, Current opinion in biotechnology.

[175]  S. Bell,et al.  Structural Basis for the Properties of Two Single‐Site Proline Mutants of CYP102A1 (P450BM3) , 2010, Chembiochem : a European journal of chemical biology.

[176]  S. Bell,et al.  P450(BM3) (CYP102A1): connecting the dots. , 2012, Chemical Society reviews.

[177]  Heung-Chae Jung,et al.  Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3 , 2010 .

[178]  M. Sutcliffe,et al.  The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction , 1996, Nature Structural Biology.

[179]  X. Ribas,et al.  Stereospecific C-H oxidation with H2O2 catalyzed by a chemically robust site-isolated iron catalyst. , 2009, Angewandte Chemie.

[180]  C. W. Fisher,et al.  Purification and enzymatic properties of a recombinant fusion protein expressed in Escherichia coli containing the domains of bovine P450 17A and rat NADPH-P450 reductase. , 1994, Archives of biochemistry and biophysics.

[181]  Hidehiko Hirakawa,et al.  Molecular Assembly of P450 with Ferredoxin and Ferredoxin Reductase by Fusion to PCNA , 2010, Chembiochem : a European journal of chemical biology.

[182]  K. R. Marshall,et al.  Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium. , 2004, Biochemistry.

[183]  S. Sligar,et al.  Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions. , 1993, Biochemistry.

[184]  C. W. Fisher,et al.  The function of recombinant cytochrome P450s in intact Escherichia coli cells: the 17 alpha-hydroxylation of progesterone and pregnenolone by P450c17. , 1997, Archives of biochemistry and biophysics.

[185]  T. Poulos,et al.  Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[186]  Braunegg,et al.  The Concept of Docking/Protecting Groups in Biohydroxylation. , 1999, Angewandte Chemie.

[187]  D. Monti,et al.  Redox reactions catalyzed by isolated enzymes. , 2011, Chemical reviews.

[188]  P. Ortiz de Montellano,et al.  Rearrangement reactions catalyzed by cytochrome P450s. , 2011, Archives of biochemistry and biophysics.

[189]  V. Urlacher,et al.  Catalytic Hydroxylation in Biphasic Systems using CYP102A1 Mutants , 2005 .

[190]  David Baker,et al.  A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). , 2009, ACS chemical biology.

[191]  T. Poulos,et al.  Structural biology of redox partner interactions in P450cam monooxygenase: a fresh look at an old system. , 2011, Archives of biochemistry and biophysics.

[192]  M. Waterman,et al.  The use of random chimeragenesis to study structure/function properties of rat and human P450c17. , 2000, Archives of biochemistry and biophysics.

[193]  T. Baillie,et al.  Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. , 2008, Chemical research in toxicology.

[194]  M. Sanford,et al.  Transition metal catalyzed oxidative functionalization of carbon-hydrogen bonds , 2006 .

[195]  T. Rushmore,et al.  Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites. , 2000, Metabolic engineering.

[196]  Y. Sakai,et al.  PropaneMonooxygenase and NAD+-Dependent Secondary AlcoholDehydrogenase in Propane Metabolism by Gordonia sp.StrainTY-5 , 2003, Journal of bacteriology.

[197]  A. Munro,et al.  Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. , 2007, Natural product reports.

[198]  P. R. Montellano Hydrocarbon hydroxylation by cytochrome P450 enzymes. , 2010 .

[199]  P. Hlavica Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas. , 2009, Biotechnology advances.

[200]  Frances H Arnold,et al.  Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. , 2007, Angewandte Chemie.

[201]  Christopher A. Voigt,et al.  Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach. , 2004, Chemistry & biology.

[202]  Manfred T Reetz,et al.  Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution , 2011, Nature Chemistry.

[203]  H. Weber,et al.  The concept of docking and protecting groups in biohydroxylation. , 2001, Chemistry.

[204]  G. Grogan Cytochromes P450: exploiting diversity and enabling application as biocatalysts. , 2011, Current opinion in chemical biology.

[205]  John A. Robinson,et al.  An oxidative phenol coupling reaction catalyzed by oxyB, a cytochrome P450 from the vancomycin-producing microorganism. , 2004, Angewandte Chemie.

[206]  F. Arnold,et al.  A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. , 2009, Chemistry.

[207]  N. Turner,et al.  Identification of a New Class of Cytochrome P450 from a Rhodococcus sp , 2002, Journal of bacteriology.

[208]  S. Bell,et al.  Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam. , 2002, Journal of the American Chemical Society.

[209]  T. Egawa,et al.  Evidence for compound I formation in the reaction of cytochrome P450cam with m-chloroperbenzoic acid. , 1994, Biochemical and biophysical research communications.

[210]  Eric F. Johnson,et al.  Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.

[211]  A. McDermott,et al.  Observation of ligand binding to cytochrome P450 BM-3 by means of solid-state NMR spectroscopy. , 2005, Journal of the American Chemical Society.

[212]  A. Parret,et al.  A novel class of self-sufficient cytochrome P450 monooxygenases in prokaryotes. , 2002, Trends in microbiology.

[213]  Huimin Zhao,et al.  Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution. , 2010, Chemical communications.

[214]  N. Misawa,et al.  Functional expression system for cytochrome P450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp. NCIMB 9784 , 2006, Applied Microbiology and Biotechnology.

[215]  Mikhail G. Shapiro,et al.  Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine , 2010, Nature Biotechnology.

[216]  John H. White,et al.  A Self-sufficient Cytochrome P450 with a Primary Structural Organization That Includes a Flavin Domain and a [2Fe-2S] Redox Center* , 2003, Journal of Biological Chemistry.

[217]  R. Croteau,et al.  Cytochrome P450 oxygenases of Taxol biosynthesis , 2006, Phytochemistry Reviews.

[218]  J. Dawson,et al.  Uncoupling Oxygen Transfer and Electron Transfer in the Oxygenation of Camphor Analogues by Cytochrome P450-CAM , 1995, The Journal of Biological Chemistry.

[219]  G. Gilardi,et al.  Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego , 2006, JBIC Journal of Biological Inorganic Chemistry.

[220]  C. Helliwell,et al.  Arabidopsis ent-kaurene oxidase catalyzes three steps of gibberellin biosynthesis. , 1999, Plant physiology.

[221]  Ke Chen,et al.  Total synthesis of eudesmane terpenes by site-selective C–H oxidations , 2009, Nature.

[222]  M. Joyce,et al.  A Single Mutation in Cytochrome P450 BM3 Induces the Conformational Rearrangement Seen upon Substrate Binding in the Wild-type Enzyme* , 2004, Journal of Biological Chemistry.

[223]  E. G. Funhoff,et al.  Cytochrome P450 Alkane Hydroxylases of the CYP153 Family Are Common in Alkane-Degrading Eubacteria Lacking Integral Membrane Alkane Hydroxylases , 2006, Applied and Environmental Microbiology.

[224]  F. Arnold,et al.  Directed Evolution of a Cytochrome P450 Monooxygenase for Alkane Oxidation , 2001 .

[225]  David J. Schuller,et al.  Crystal Structure of a Thermophilic Cytochrome P450 from the Archaeon Sulfolobus solfataricus * , 2000, The Journal of Biological Chemistry.

[226]  J. Bercaw,et al.  Understanding and exploiting C–H bond activation , 2002, Nature.